Author

William Sandborn 1

1 University of California,San Diego,United States

Clinical Remission Demonstrated with Oral Ozanimod in the Overall Population and Across Multiple Subgroups of Patients with Moderately to Severely Active Ulcerative Colitis in the TOUCHSTONE Trial

Brian G. Feagan, William Sandborn, Geert R. D'Haens, Steve Hanauer, Douglas C. Wolf, Severine Vermeire, Subrata Ghosh, Annkatrin Petersen Jappelli, Steven Ye Hua, Kevin Shan, W Jerry Liu

CLINICALLY ADJUSTED VERSUS THERAPEUTIC DRUG MONITORING DOSING REGIMENS WITH ADALIMUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM THE SERENE-CD MAINTENANCE STUDY

Silvio Danese, William Sandborn, Edward V. Loftus Jr., Stephen B Hanauer, Stefan Schreiber, Laurent Peyrin-Biroulet, Remo Panaccione, Julian Panés, Filip Baert, Jean-Frederic Colombel, Marc Ferrante, Edouard Louis, Alessandro Armuzzi, Sasikiran Goteti, John Liu, Nael M. Mostafa, Thao Doan, Joel Petersson, Anne M. Robinson

CLINICALLY MEANINGFUL IMPROVEMENTS IN HEALTH-RELATED QUALITY OF LIFE AMONG PATIENTS WITH ULCERATIVE COLITIS TREATED WITH FILGOTINIB - A POST HOC ANALYSIS OF SELECTION

William J. Sandborn

CLINICALLY MEANINGFUL IMPROVEMENTS IN HEALTH-RELATED QUALITY OF LIFE AMONG PATIENTS WITH ULCERATIVE COLITIS TREATED WITH FILGOTINIB – A POST HOC ANALYSIS OF SELECTION

Silvio Danese, Laurent Peyrin-Biroulet, William J. Sandborn, Virginia Taliadouros, Alessandra Oortwijn, Stefan Schreiber, Ken Hasegawa, Javaria Mona Khalid, Robin Besuyen

COBITOLIMOD FOR MODERATE-TO-SEVERE LEFT-SIDED ULCERATIVE COLITIS (CONDUCT): A PHASE IIB, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING TRIAL

Raja Atreya, Laurent Peyrin–Biroulet, Andrii Klymenko, Monica Augustyn, Igor Bakulin, Dusan Slankamenac, Pal Miheller, Antonio Gasbarrini, Xavier Hebuterne, Karin Arnesson, Thomas Knittel, Jan Kowalski, Markus F. Neurath, William Sandborn, Walter Reinisch

COMPARATIVE BIOAVAILABILITY OF NOVEL CYCLOSPORINE FORMULATIONS VERSUS REFERENCE ORAL CYCLOSPORINE IN HEALTHY SUBJECTS UNDER FASTING CONDITIONS

William Sandborn

COMPARATIVE BIOAVAILABILITY OF NOVEL CYCLOSPORINE FORMULATIONS VERSUS REFERENCE ORAL CYCLOSPORINE IN HEALTHY SUBJECTS UNDER FASTING CONDITIONS

William Sandborn, Jesse Hall, Peter Gardzinski, Mónica Rosa, Bernard McDonald, Walter Reinisch

COMPOSITE REMISSION MEASURES IN EARLY CROHN’S DISEASE: A POST-HOC ANALYSIS OF THE SONIC TRIAL

Walter Reinisch, Gerassimos J. Mantzaris, Asher Kornbluth, A Oortwijn, G S Bevelander, Freddy Cornillie, Jean-Frederic Colombel, William Sandborn

CONCORDANCE OF STOOL FREQUENCY AND ABDOMINAL PAIN MEASURES WITH SIMPLE ENDOSCOPIC SCORE FOR CROHN'S DISEASE

James D Lewis, Paul Rutgeerts, Geert R. D'Haens, Jean-Frederic Colombel, William Sandborn, Walter Reinisch, James Butler, Jen Fue Maa, Anne M. Robinson

CORTICOSTEROID DOSE REDUCTION IN ULCERATIVE COLITIS PATIENTS TREATED WITH VEDOLIZUMAB

Edward V. Loftus Jr., Corey A Siegel, Remo Panaccione, William Sandborn, Michael Smyth, Alexandra Green, Jing Xu, Brihad Abhyankar

Item 21 - 30 / 206
1 2
3
4 5 6 7
...
20 21